Why These 4 Stocks Have Started the Week Off on the Right Foot

Another Monday mover is AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG), which was up by almost 3% after reporting preliminary fourth quarter sales figures in line with consensus estimates and issuing an upbeat guidance for fiscal year 2016. Shares have since slipped back but are still up slightly for the day.

“2015 was a transformational year filled with acquisition, integration and transition as we built a strong and diversified base of business with significant growth potential. Today we reported preliminary 2015 product revenues that were more than triple the revenues reported in 2014, and we anticipate achieving significant annual earnings in 2015 for the first time in the company’s history,” said William Heiden, AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG)’s Chief Executive Officer.

Same as in the prior quarter, AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) counted 29 hedge fund backers within our database at the end of the third quarter, with them holding about 28.4% of the company’s outstanding shares. William Leland Edwards’ Palo Alto Investors was the largest shareholder in our system, with more than 2.77 million shares of the company, worth over $110 million.

Finally, we come to Tenet Healthcare Corp (NYSE:THC), which is up by over 2% on no specific news. The small-cap healthcare services company has been going through some strategic initiatives, which analysts and investors expect to act as a catalyst for growth. In an article published Monday, analysts at Zacks noted that, “Recently, the company divested its North Carolina hospitals to Duke LifePoint Healthcare. Additionally, the company completed the joint venture with Baylor Scott & White Health. While the divestiture is expected to help the company focus on its core operations and thus boost its operating revenues, the partnership is a clear reflection of the company’s focus on increasing its scale of operation.”

In addition, Tenet Healthcare Corp (NYSE:THC) extended its partnership with Aetna Inc (NYSE:AET) last month. The four-year extension “is undoubtedly a significant move by Tenet Healthcare to reach its goal of associating itself with other insurance companies so as to bring superior quality, convenient and affordable choices to its members,” the Zacks analysts asserted.

Despite the aforementioned strategic review, hedge funds seem to be growing less confident in Tenet Healthcare Corp (NYSE:THC). Over the third quarter of 2015, the number of funds in our database with long stakes in the company fell by more than 8% to 44. These 44 firms, however, owned more than 32% of the company’s shares, with Larry Robbins’ Glenview Capital holding the largest stake of them all, totaling about 16.49 million shares worth approximately $608 million.

Disclosure: Javier Hasse holds no positions in any of the securities mentioned in this article.